Pre-order Enquiry
Request Free Sample
Global Conjugate Vaccine Market Professional Survey Report 2019
SKU ID : QYR-14651138 | Publishing Date : 04-Sep-2019 | No. of pages : 119
Conjugate vaccines are formed by covalently bonding a weak antigen to the strong antigen. It boosts the hosts’ immune response. Conjugate vaccines are germ specific and can identify targeted germ only, so it can be used as a preventative measure to provide additional protection. Conjugate vaccines are used to treat Hib (Haemophilus influenzae type b) disease, Hepatitis B, HPV (Human papillomavirus), Whooping cough (part of the DTaP combined vaccine), Pneumococcal disease, Meningococcal disease, and Shingles.
The rising occurrence of diseases caused by microorganisms, increasing awareness about prevention of infectious diseases, and an increasing number of regulatory approvals to the vaccines are expected to drive the growth of the market. Moreover, rising R&D spending and aggressive strategies adopted by top players such as new product launches are contributing to the growth of the market.
The global Conjugate Vaccine market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Conjugate Vaccine volume and value at global level, regional level and company level. From a global perspective, this report represents overall Conjugate Vaccine market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Conjugate Vaccine in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Conjugate Vaccine manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
GlaxoSmithKline
Pfizer
Merck
Sanofi Pasteur
CSL
Emergent BioSolutions
Johnson & Johnson
Medimmune
Astellas Pharma
Serum Institute of India
Bavarian Nordi
Mitsubishi Tanabe Pharma
Daiichi Sankyo Company
Fablife
SutroVax
Sinovac Biotech
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Monovalent
Multivalent
Segment by Application
Hospitals
Clinics
The rising occurrence of diseases caused by microorganisms, increasing awareness about prevention of infectious diseases, and an increasing number of regulatory approvals to the vaccines are expected to drive the growth of the market. Moreover, rising R&D spending and aggressive strategies adopted by top players such as new product launches are contributing to the growth of the market.
The global Conjugate Vaccine market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Conjugate Vaccine volume and value at global level, regional level and company level. From a global perspective, this report represents overall Conjugate Vaccine market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Conjugate Vaccine in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Conjugate Vaccine manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
GlaxoSmithKline
Pfizer
Merck
Sanofi Pasteur
CSL
Emergent BioSolutions
Johnson & Johnson
Medimmune
Astellas Pharma
Serum Institute of India
Bavarian Nordi
Mitsubishi Tanabe Pharma
Daiichi Sankyo Company
Fablife
SutroVax
Sinovac Biotech
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Monovalent
Multivalent
Segment by Application
Hospitals
Clinics
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Request Sample
Request Discount
